<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="3.0" xml:lang="EN">
  <front>
    <journal-meta><journal-id journal-id-type="nlm-ta">PLoS ONE</journal-id><journal-id journal-id-type="publisher-id">plos</journal-id><journal-id journal-id-type="pmc">plosone</journal-id><!--===== Grouping journal title elements =====--><journal-title-group><journal-title>PLoS ONE</journal-title></journal-title-group><issn pub-type="epub">1932-6203</issn><publisher>
        <publisher-name>Public Library of Science</publisher-name>
        <publisher-loc>San Francisco, USA</publisher-loc>
      </publisher></journal-meta>
    <article-meta><article-id pub-id-type="publisher-id">PONE-D-11-15492</article-id><article-id pub-id-type="doi">10.1371/journal.pone.0025930</article-id><article-categories>
        <subj-group subj-group-type="heading">
          <subject>Research Article</subject>
        </subj-group>
        <subj-group subj-group-type="Discipline-v2">
          <subject>Biology</subject>
          <subj-group>
            <subject>Anatomy and physiology</subject>
            <subj-group>
              <subject>Cardiovascular system</subject>
              <subj-group>
                <subject>Circulatory physiology</subject>
              </subj-group>
            </subj-group>
          </subj-group>
        </subj-group>
        <subj-group subj-group-type="Discipline-v2">
          <subject>Medicine</subject>
          <subj-group>
            <subject>Cardiovascular</subject>
            <subj-group>
              <subject>Stroke</subject>
            </subj-group>
          </subj-group>
          <subj-group>
            <subject>Epidemiology</subject>
            <subj-group>
              <subject>Clinical epidemiology</subject>
            </subj-group>
          </subj-group>
          <subj-group>
            <subject>Neurology</subject>
            <subj-group>
              <subject>Cerebrovascular diseases</subject>
              <subj-group>
                <subject>Hemorrhagic stroke</subject>
              </subj-group>
            </subj-group>
          </subj-group>
          <subj-group>
            <subject>Radiology</subject>
            <subj-group>
              <subject>Diagnostic radiology</subject>
              <subj-group>
                <subject>Magnetic resonance imaging</subject>
              </subj-group>
            </subj-group>
          </subj-group>
        </subj-group>
        <subj-group subj-group-type="Discipline">
          <subject>Public Health and Epidemiology</subject>
          <subject>Physiology</subject>
          <subject>Neurological Disorders</subject>
          <subject>Radiology and Medical Imaging</subject>
        </subj-group>
      </article-categories><title-group><article-title>Dynamic Temporal Change of Cerebral Microbleeds: Long-Term Follow-Up MRI Study</article-title><alt-title alt-title-type="running-head">Dynamic Temporal Change of Cerebral Microbleeds</alt-title></title-group><contrib-group>
        <contrib contrib-type="author" equal-contrib="yes" xlink:type="simple">
          <name name-style="western">
            <surname>Lee</surname>
            <given-names>Seung-Hoon</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
            <sup>1</sup>
          </xref>
          <xref ref-type="aff" rid="aff2">
            <sup>2</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author" equal-contrib="yes" xlink:type="simple">
          <name name-style="western">
            <surname>Lee</surname>
            <given-names>Soon-Tae</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
            <sup>1</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author" xlink:type="simple">
          <name name-style="western">
            <surname>Kim</surname>
            <given-names>Beom Joon</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
            <sup>1</sup>
          </xref>
          <xref ref-type="aff" rid="aff2">
            <sup>2</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author" xlink:type="simple">
          <name name-style="western">
            <surname>Park</surname>
            <given-names>Hee-Kwon</given-names>
          </name>
          <xref ref-type="aff" rid="aff3">
            <sup>3</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author" xlink:type="simple">
          <name name-style="western">
            <surname>Kim</surname>
            <given-names>Chi-Kyung</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
            <sup>1</sup>
          </xref>
          <xref ref-type="aff" rid="aff2">
            <sup>2</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author" xlink:type="simple">
          <name name-style="western">
            <surname>Jung</surname>
            <given-names>Keun-Hwa</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
            <sup>1</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author" xlink:type="simple">
          <name name-style="western">
            <surname>Roh</surname>
            <given-names>Jae-Kyu</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
            <sup>1</sup>
          </xref>
          <xref ref-type="corresp" rid="cor1">
            <sup>*</sup>
          </xref>
        </contrib>
      </contrib-group><aff id="aff1"><label>1</label><addr-line>Department of Neurology, Seoul National University College of Medicine, Seoul, Republic of Korea</addr-line>       </aff><aff id="aff2"><label>2</label><addr-line>Clinical Research Center for Stroke, Seoul National University Hospital, Seoul, Republic of Korea</addr-line>       </aff><aff id="aff3"><label>3</label><addr-line>Department of Neurology, Inha University Hospital, Incheon, Republic of Korea</addr-line>       </aff><contrib-group>
        <contrib contrib-type="editor" xlink:type="simple">
          <name name-style="western">
            <surname>Hernandez</surname>
            <given-names>Adrian V.</given-names>
          </name>
          <role>Editor</role>
          <xref ref-type="aff" rid="edit1"/>
        </contrib>
      </contrib-group><aff id="edit1">Lerner Research Institute, Cleveland Clinic, United States of America</aff><author-notes>
        <corresp id="cor1">* E-mail: <email xlink:type="simple">rohjk@snu.ac.kr</email></corresp>
        <fn fn-type="con">
          <p>Conceived and designed the experiments: S-HL J-KR. Performed the experiments: S-HL S-TL H-KP K-HJ C-KK. Analyzed the data: S-HL S-TL BJK K-HJ C-KK. Contributed reagents/materials/analysis tools: S-HL BJK J-KR. Wrote the paper: S-HL S-TL BJK J-KR.</p>
        </fn>
      <fn fn-type="conflict">
        <p>The authors have declared that no competing interests exist.</p>
      </fn></author-notes><pub-date pub-type="collection">
        <year>2011</year>
      </pub-date><pub-date pub-type="epub">
        <day>11</day>
        <month>10</month>
        <year>2011</year>
      </pub-date><volume>6</volume><issue>10</issue><elocation-id>e25930</elocation-id><history>
        <date date-type="received">
          <day>4</day>
          <month>7</month>
          <year>2011</year>
        </date>
        <date date-type="accepted">
          <day>13</day>
          <month>9</month>
          <year>2011</year>
        </date>
      </history><!--===== Grouping copyright info into permissions =====--><permissions><copyright-year>2011</copyright-year><copyright-holder>Lee et al</copyright-holder><license><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p></license></permissions><abstract>
        <sec>
          <title>Background</title>
          <p>Cerebral microbleeds (MBs) are understood as an important radiologic marker of intracerebral hemorrhage. We sought to investigate the temporal changes of MBs and clinical factors associated with the changes using long-term follow-up MRI.</p>
        </sec>
        <sec>
          <title>Methods/Principal Findings</title>
          <p>From October 2002 to July 2006, we prospectively enrolled patients with stroke or transient ischemic attack, and followed-up their brain MRIs with an interval &gt;12 mo. We compared demographic factors, vascular risk factors, laboratory findings, and radiologic factors according to the presence or changes of MBs. A total of 224 patients successfully completed the follow-up examinations (mean, 27 months). Newly developed MBs were noted in 10 patients (6.8%) among those without MBs at baseline (n = 148), and in those with MBs at baseline (n = 76), the MB count had decreased in 11 patients (14.5%), and increased in 41 patients (53.9%). The estimated annual rate of change of MB numbers was 0.80 lesions per year in all patients, a value which became greater in those patients who exhibited MBs at baseline (MBs≥5, 5.43 lesions per year). Strokes due to small vessel occlusion and intracerebral hemorrhage, as well as white matter lesions were independently associated with an increased MB count, whereas the highest quartile of low-density lipoprotein (LDL) cholesterol was associated with a decreased MB count.</p>
        </sec>
        <sec>
          <title>Conclusion</title>
          <p>During the follow-up period, most of MBs showed dynamic temporal change. Symptomatic or asymptomatic small vessel diseases appear to act as risk factors while in contrast, a high level of LDL cholesterol may act as a protective factor against MB increase.</p>
        </sec>
      </abstract><funding-group><funding-statement>This research was supported by Basic Science Research Program through the National Research Foundation of Korea funded by the Ministry of Education, Science and Technology (2011-0026315). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</funding-statement></funding-group><counts>
        <page-count count="7"/>
      </counts></article-meta>
  </front>
  <body>
    <sec id="s1">
      <title>Introduction</title>
      <p>Cerebral microbleeds (MBs), which are seen as small, focal, dark signal intensity lesions on T2*-weighted gradient-echo magnetic resonance imaging (MRI), pathologically represent the perivascular extravasation of blood resulting from advanced cerebral microangiopathy, such as lipohyalinosis <xref ref-type="bibr" rid="pone.0025930-Greenberg1">[1]</xref>. Old age <xref ref-type="bibr" rid="pone.0025930-Roob1">[2]</xref>, chronic hypertension <xref ref-type="bibr" rid="pone.0025930-Tanaka1">[3]</xref>, left ventricular hypertrophy <xref ref-type="bibr" rid="pone.0025930-Lee1">[4]</xref>, low serum cholesterol <xref ref-type="bibr" rid="pone.0025930-Lee2">[5]</xref>, and cerebral amyloid angiopathy <xref ref-type="bibr" rid="pone.0025930-Greenberg2">[6]</xref> may be associated with the presence or increase of MBs. Further these lesions may be associated with the risks of future intracerebral hemorrhage with numerical and regional associations <xref ref-type="bibr" rid="pone.0025930-Lee3">[7]</xref>, and aspirin or warfarin-associated intracerebral hemorrhage <xref ref-type="bibr" rid="pone.0025930-Wong1">[8]</xref>, <xref ref-type="bibr" rid="pone.0025930-Lee4">[9]</xref>, thus serving a role as a risk factor or at least a radiological risk marker. In addition, as hemorrhage-type microangiopathy, MBs are positively correlated with the radiologic findings of ischemia-type microangiopathy - silent lacunar infarction and white matter lesions - in terms of the lesion extent; however, they are relatively different in terms of spatial distribution <xref ref-type="bibr" rid="pone.0025930-Lee5">[10]</xref>. Furthermore, it has been suggested that MBs may play an active role in cognitive function <xref ref-type="bibr" rid="pone.0025930-Henneman1">[11]</xref>. Generally, there is increasing evidence relating to the importance of MB detection in various aspects of clinical practice.</p>
      <p>Despite its suggested importance, most previous studies have been based on cross-sectional design which is questionable given that the longitudinal temporal changes of MBs have yet to be elucidated. In the current follow-up MRI study, we observed temporal changes of MBs in a prospective series from a stroke population, and attempted to determine factors associated with lesion changes.</p>
    </sec>
    <sec id="s2" sec-type="methods">
      <title>Methods</title>
      <sec id="s2a">
        <title>Study design</title>
        <p>In order to elucidate the long-term temporal changes of MBs after stroke or transient ischemic attack (TIA), we designed a long-term retrospective cohort study. From October 2002, we enrolled stroke or TIA patients who had been admitted to the stroke care unit of our hospital. We restricted the study population to patients who had been admitted within seven days of onset. At baseline, all patients underwent a complete set of clinical tests – past medical history, neurological examination, National Institutes of Health Stroke Scale (NIHSS) scoring, and basic laboratory tests for stroke. Further, all patients received standard stroke and best medical therapy during hospitalization. Follow-up brain MRIs were conducted between December 2007 and February 2008, with an interval of at least 12 months from the initial MRIs. If a patient had already undergone a brain MRI due to various medical conditions in the six months prior to their follow-up MRI visit, we did not perform the MRI again. Conduction of follow-up MRI with an interval of 12 months after stroke is covered by the National Health Insurance System in Korea, and we obtained informed consents from the participants verbally. We obtained medical information of the included patients from the electronic medical record system of our hospital. When lost to follow-up, we contacted the patient or the family members by telephone to confirm their status. Despite this effort, if a patient's status could not be confirmed, we classified the case as follow-up loss. In cases when the patient had expired, the date and cause of death according to the International Classification of Diseases (10th Revision), were recorded. To confirm the accuracy of mortality information, we matched our data to the nationwide official data on death certification provided by the National Statistical Office, data which have been used in previous studies as reliable data <xref ref-type="bibr" rid="pone.0025930-Jee1">[12]</xref>. This study was approved by the Institutional Review Board of Seoul National University Hospital (H-0805-035-243).</p>
      </sec>
      <sec id="s2b">
        <title>Determination of clinical variables and laboratory tests</title>
        <p>We recorded demographic data (age and gender), conventional risk factors, and important laboratory data for all subjects. Conventional risk factors included hypertension, diabetes, hyperlipidemia, and being a current smoker. Hypertension was diagnosed as present if patients exhibited a systolic blood pressure &gt;140 mm Hg or a diastolic blood pressure &gt;90 mm Hg at discharge, or had a history of diagnosis of hypertension and anti-hypertensive medications. Diabetes was diagnosed as present if subjects exhibited a fasting glucose level ≥7.0 mmol/L (126 mg/dL) or had a history of diagnosis of diabetes and anti-diabetic medications. A diagnosis of hyperlipidemia was made in patients with a history of using cholesterol-lowering agents or who had a fasting serum total cholesterol level &gt;6.2 mmol/L (240 mg/dL) at admission. Body mass index was calculated based on body weight and height (kg/m<sup>2</sup>). With the exception of hemorrhagic stroke, subtypes of ischemic stroke were determined by consensus from a panel of stroke neurologists the Trial of Org 10172 in Acute Stroke Treatment (TOAST) criteria with minor modifications <xref ref-type="bibr" rid="pone.0025930-Adams1">[13]</xref>. Fasting blood samples were drawn within 24 hours of admission, and examined using a standard battery of biochemical and hematological tests. Lipid profiles included total cholesterol, low-density lipoprotein (LDL) cholesterol, high-density lipoprotein cholesterol, and triglycerides.</p>
      </sec>
      <sec id="s2c">
        <title>Brain imaging protocols</title>
        <p>Magnetic resonance images were obtained using a 1.5T superconducting magnet (GE Medical Systems, Milwaukee, WI, USA). In terms of protocol, the current study employed T2*-weighted gradient-echo [repetition time/echo time (TR/TE), 500/15 ms; flip angle, 26°; slice thickness, 5 mm; matrix size, 256×192) and fluid-attenuated inversion recovery (FLAIR; TR/TE, 8500/96 ms; inversion time, 2100 ms; flip angle, 26°; slice thickness, 5 mm; matrix size, 256×192) imaging.</p>
        <p>In accordance with the recommended criteria <xref ref-type="bibr" rid="pone.0025930-Greenberg1">[1]</xref>, the MBs were defined as well-defined focal areas of dark signal intensity measuring less than 5 mm in diameter with blooming artifacts on gradient-echo MRI. We did not include lesions that were within the subarachnoid space or areas of symmetric hypointensity of the globus pallidus, given that they were likely to represent adjacent pial blood vessels and calcification, respectively. The numbers of the lesions were counted throughout the entire brain by two neurologists (BJ Kim and CK Kim) who were blind to the clinical characteristics.</p>
        <p>White matter lesions were evaluated by FLAIR MRI, and classified into four grades: Grade 0, no abnormality or minimal periventricular signal hyperintensities in the form of caps confined exclusively to the anterior horns or rims lining the ventricles; Grade 1, hyperintensities in both the anterior and posterior horns of the lateral ventricles or periventricular unifocal patches; Grade 2, multiple periventricular hyperintense punctate lesions and their early confluence; and Grade 3, multiple areas of high signal intensity reaching confluence in the periventricular region <xref ref-type="bibr" rid="pone.0025930-Fazekas1">[14]</xref>.</p>
      </sec>
      <sec id="s2d">
        <title>Statistical analysis</title>
        <p>Means for continuous variables and proportions for categorical variables were compared using student <italic>t</italic>-tests and χ<sup>2</sup>-tests as appropriate. Data were expressed as means ± standard deviation (SD) or as numbers (percentages). To identify independent risk factors for MBs at baseline, univariate and multivariate logistic regression analysis was performed to calculate crude and adjusted odds ratios (ORs) with 95% confidence intervals (CIs). In this analysis, levels of lipid profiles were categorized into quartiles, and the highest or lowest values were used as appropriate, given that the relationships between values of lipid profiles and the presence of MBs were not linear. For comparisons among multiple groups from the patients with MBs at baseline (n = 76), a one-way analysis of variance (ANOVA) with Dunnett's post-hoc comparisons was used for continuous values, and the chi-square test was used for categorical variables.</p>
        <p>To examine temporal change of MB, we calculated annual rates of change of MB counts by analyzing a mean of difference between numbers of MBs at follow-up and numbers at initial visit divided by the follow-up period (number of changes per year). In addition, we used generalized estimating equations (GEE) to evaluate the relationship between several predictor variables related to MB count <xref ref-type="bibr" rid="pone.0025930-Zeger1">[15]</xref>. These equations were necessary because of the clustered and correlated nature of counting MBs using two individual brain MRIs longitudinally over time. The repeated counting for each patient was treated as a cluster. Further, GEE models were estimated that used an exchangeable correlation matrix, assuming that outcomes for individual MR imaging were equally correlated within each patient but statistically independent between individuals. Univariable and multivariable analyses was performed using GEE models utilizing MB count as a dependent variable with Poisson log-linear link function. Clinically relevant variables or potentially significant variables from the univariate analyses (i.e. <italic>p</italic>&lt;0.1) were subsequently chosen to construct a multivariable analysis model. Data produced by the GEE models were presented as rate ratios (RRs) with 95% CIs. All statistical analyses were conducted using SPSS for Windows, version 17.0 (SPSS Inc., Chicago, IL, USA), and statistical significance was accepted at the <italic>p</italic>&lt;0.05 level.</p>
      </sec>
    </sec>
    <sec id="s3">
      <title>Results</title>
      <sec id="s3a">
        <title>Study population</title>
        <p>Initially, 591 patients with acute stroke or TIA were screened (<xref ref-type="fig" rid="pone-0025930-g001">Fig. 1</xref>). Among them, 165 patients refused participation in this study, and thus, 426 patients represented the final number of patients at baseline. Further, 32 patients (7.5%) were lost to follow-up, and 76 patients (17.8%) could not undergo follow-up brain MRI due to various medical reasons - irritability, claustrophobia, decreased performance, unstable medical condition, concomitant diseases, and patient delivery problem because of long distance between the resident area and our center. In addition, 94 patients (22.1%) expired during the study period. As a result, a total of 224 patients (52.6%) completed our study protocols and their data were included in the final analysis.</p>
        <fig id="pone-0025930-g001" position="float">
          <object-id pub-id-type="doi">10.1371/journal.pone.0025930.g001</object-id>
          <label>Figure 1</label>
          <caption>
            <title>Flow chart for the study sample.</title>
          </caption>
          <graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0025930.g001" xlink:type="simple"/>
        </fig>
      </sec>
      <sec id="s3b">
        <title>Baseline characteristics</title>
        <p>Among the 224 patients analyzed, there were 148 men (66.1%) and 76 women (33.9%), and ages ranged from 31 to 95 years (mean, 64.6±11.3 years). Intervals between initial and follow-up MRIs ranged from 12.0 to 62.6 months (mean, 27.5±12.3 months). At baseline, there were 209 patients with stroke and 22 patients with TIA. Stroke subtypes were as follows: 58 large-artery atherothromboses, 60 small-vessel occlusions, 33 cardioembolisms, 31 other determined or undetermined etiologies, and 20 intracerebral hemorrhages. On initial gradient-echo MRIs, 76 patients (33.9%) had cerebral MBs, and the numbers of MBs in the whole brain area ranged 0 to 81 (mean per patient, 3.4±10.5 lesions). When we compared the prevalence of MBs according to stroke subtypes, the highest was in intracerebral hemorrhage patients at 12 (57.1%). TIA represented the next highest prevalence with 4 (26.4% in all TIA patients), followed by large-artery atherothrombosis with 17 (28.8%), small-vessel occlusion with 23 (37.7%), cardioembolism with 9 (28.1%), and 8 with other determined or undetermined etiologies (26.7%). Baseline characteristics have been provided in <xref ref-type="table" rid="pone-0025930-t001">Table 1</xref>. The patients with MBs at baseline showed a higher frequency of hypertension, lower frequency of diabetes, and lower levels of hemoglobin A1c than those patients without MBs.</p>
        <table-wrap id="pone-0025930-t001" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0025930.t001</object-id><label>Table 1</label><caption>
            <title>Baseline characteristics of patients according to presence of MBs at baseline.</title>
          </caption><!--===== Grouping alternate versions of objects =====--><alternatives><graphic id="pone-0025930-t001-1" mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0025930.t001" xlink:type="simple"/><table>
            <colgroup span="1">
              <col align="left" span="1"/>
              <col align="center" span="1"/>
              <col align="center" span="1"/>
            </colgroup>
            <thead>
              <tr>
                <td align="left" colspan="1" rowspan="1"/>
                <td align="left" colspan="2" rowspan="1">MBs at baseline</td>
              </tr>
              <tr>
                <td align="left" colspan="1" rowspan="1"/>
                <td align="left" colspan="1" rowspan="1">Absent (n = 148)</td>
                <td align="left" colspan="1" rowspan="1">Present (n = 76)</td>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td align="left" colspan="1" rowspan="1">Gender (men)</td>
                <td align="left" colspan="1" rowspan="1">96 (64.9%)</td>
                <td align="left" colspan="1" rowspan="1">52 (68.4%)</td>
              </tr>
              <tr>
                <td align="left" colspan="1" rowspan="1">Age, years</td>
                <td align="left" colspan="1" rowspan="1">64.8±11.2</td>
                <td align="left" colspan="1" rowspan="1">64.5±11.5</td>
              </tr>
              <tr>
                <td align="left" colspan="1" rowspan="1">Body mass index</td>
                <td align="left" colspan="1" rowspan="1">23.8±3.1</td>
                <td align="left" colspan="1" rowspan="1">23.5±3.1</td>
              </tr>
              <tr>
                <td align="left" colspan="1" rowspan="1">Hypertension<xref ref-type="table-fn" rid="nt103">*</xref></td>
                <td align="left" colspan="1" rowspan="1">95 (64.2%)</td>
                <td align="left" colspan="1" rowspan="1">59 (77.6%)</td>
              </tr>
              <tr>
                <td align="left" colspan="1" rowspan="1">Diabetes<xref ref-type="table-fn" rid="nt103">*</xref></td>
                <td align="left" colspan="1" rowspan="1">60 (40.5%)</td>
                <td align="left" colspan="1" rowspan="1">17 (22.4%)</td>
              </tr>
              <tr>
                <td align="left" colspan="1" rowspan="1">Hyperlipidemia</td>
                <td align="left" colspan="1" rowspan="1">27 (18.2%)</td>
                <td align="left" colspan="1" rowspan="1">12 (15.8%)</td>
              </tr>
              <tr>
                <td align="left" colspan="1" rowspan="1">Smoking</td>
                <td align="left" colspan="1" rowspan="1">30 (20.3%)</td>
                <td align="left" colspan="1" rowspan="1">16 (21.1%)</td>
              </tr>
              <tr>
                <td align="left" colspan="1" rowspan="1">TIA</td>
                <td align="left" colspan="1" rowspan="1">13 (8.8%)</td>
                <td align="left" colspan="1" rowspan="1">9 (11.8%)</td>
              </tr>
              <tr>
                <td align="left" colspan="1" rowspan="1">Stroke</td>
                <td align="left" colspan="1" rowspan="1">135 (91.2%)</td>
                <td align="left" colspan="1" rowspan="1">67 (88.2%)</td>
              </tr>
              <tr>
                <td align="left" colspan="1" rowspan="1">NIHSS scores at baseline</td>
                <td align="left" colspan="1" rowspan="1">2.1±2.1</td>
                <td align="left" colspan="1" rowspan="1">2.8±5.0</td>
              </tr>
              <tr>
                <td align="left" colspan="1" rowspan="1">Total cholesterol, mg/dL</td>
                <td align="left" colspan="1" rowspan="1">183.9±46.4</td>
                <td align="left" colspan="1" rowspan="1">175.3±39.7</td>
              </tr>
              <tr>
                <td align="left" colspan="1" rowspan="1">LDL cholesterol, mg/dL</td>
                <td align="left" colspan="1" rowspan="1">112.9±39.2</td>
                <td align="left" colspan="1" rowspan="1">107.7±39.7</td>
              </tr>
              <tr>
                <td align="left" colspan="1" rowspan="1">HDL cholesterol, mg/dL</td>
                <td align="left" colspan="1" rowspan="1">44.8±12.6</td>
                <td align="left" colspan="1" rowspan="1">41.7±11.8</td>
              </tr>
              <tr>
                <td align="left" colspan="1" rowspan="1">Triglyceride, mg/dL</td>
                <td align="left" colspan="1" rowspan="1">128.8±83.3</td>
                <td align="left" colspan="1" rowspan="1">130.4±92.5</td>
              </tr>
              <tr>
                <td align="left" colspan="1" rowspan="1">Hemoglobin A1c, %<xref ref-type="table-fn" rid="nt103">*</xref></td>
                <td align="left" colspan="1" rowspan="1">6.6±1.6</td>
                <td align="left" colspan="1" rowspan="1">6.0±1.3</td>
              </tr>
              <tr>
                <td align="left" colspan="1" rowspan="1">Creatinine, mg/dL</td>
                <td align="left" colspan="1" rowspan="1">1.1±0.9</td>
                <td align="left" colspan="1" rowspan="1">1.3±1.2</td>
              </tr>
              <tr>
                <td align="left" colspan="1" rowspan="1">MBs, numbers</td>
                <td align="left" colspan="1" rowspan="1">0</td>
                <td align="left" colspan="1" rowspan="1">9.9±16.0</td>
              </tr>
            </tbody>
          </table></alternatives><table-wrap-foot>
            <fn id="nt101">
              <label/>
              <p>MB indicates microbleed; TIA, transient ischemic attack; NIHSS, National Institute of Health Stroke Scale; LDL, low-density lipoprotein; HDL, high-density lipoprotein; NS, not significant.</p>
            </fn>
            <fn id="nt102">
              <label/>
              <p>Student <italic>t</italic>-tests or χ<sup>2</sup> tests were used.</p>
            </fn>
            <fn id="nt103">
              <label/>
              <p>*indicates <italic>p</italic>&lt;0.05.</p>
            </fn>
          </table-wrap-foot></table-wrap>
      </sec>
      <sec id="s3c">
        <title>Association factors for the presence of MBs at baseline</title>
        <p>Using multivariable logistic regression analysis, we sought to determine factors associated with the presence of MBs at baseline. We entered demographic variables, vascular risk factors, some of initial laboratory findings (lipid profiles, hemoglobin A1c, and creatinine), and radiological findings (white matter lesions) after assuming that such laboratory findings and white matter lesions went unchanged after insult of stroke. The presence of diabetes was independently, but negatively associated with the presence of MBs (adjusted OR, 0.44; 95% CI, 0.22–0.90), whereas the severity of white matter lesions was a strong risk factor (adjusted OR, 2.32; 95% CI, 1.59–3.39).</p>
      </sec>
      <sec id="s3d">
        <title>Long-term temporal changes of MBs</title>
        <p>Generally, there was an increasing trend of MBs during the study period. There was no patient, in which MBs at baseline completely disappeared at follow-up, whereas 10 patients (6.8%) among the patients without MBs at baseline (n = 148) had newly developed MBs at follow-up. Thus, a total of 86 patients had MBs at follow-up (38.4%), with the total number of MBs increasing by about 1.5-fold (mean, 4.9±16.8 lesions). Among the 76 patients with MBs at baseline, the numbers of MBs decreased in 11 (14.5%) patients, and increased in 41 (53.9%). The numbers of MBs in the remaining 24 (31.6%) patients were unchanged during the follow-up. Examples of dynamic temporal changes of MB have been provided in <xref ref-type="fig" rid="pone-0025930-g002">Fig. 2</xref>.</p>
        <fig id="pone-0025930-g002" position="float">
          <object-id pub-id-type="doi">10.1371/journal.pone.0025930.g002</object-id>
          <label>Figure 2</label>
          <caption>
            <title>Dynamic changes of MBs over a long-term MRI follow-up.</title>
            <p>Some new MBs appeared (A), and some MBs disappeared in the follow-up MRI (B). Black arrows represent the MRI follow-up, while white arrow heads indicate new MBs, and dotted circles identify the location of those MBs which had disappeared.</p>
          </caption>
          <graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0025930.g002" xlink:type="simple"/>
        </fig>
        <p><xref ref-type="table" rid="pone-0025930-t002">Table 2</xref> and <xref ref-type="table" rid="pone-0025930-t003">3</xref> provide the characteristics of these 76 patients with MBs at baseline. Using an ANOVA with post-hoc tests for intra- and inter-group comparisons, we found that those with decreased numbers of MBs exhibited higher total and LDL cholesterol levels at baseline (<italic>p</italic> = 0.030 and 0.018, respectively), and higher usage of angiotensin-converting enzyme inhibitors or angiotensin-receptor blockers (<italic>p</italic> = 0.027).</p>
        <table-wrap id="pone-0025930-t002" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0025930.t002</object-id><label>Table 2</label><caption>
            <title>Baseline characteristics of patients according to temporal change of MBs counts during follow-up: part 1.</title>
          </caption><!--===== Grouping alternate versions of objects =====--><alternatives><graphic id="pone-0025930-t002-2" mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0025930.t002" xlink:type="simple"/><table>
            <colgroup span="1">
              <col align="left" span="1"/>
              <col align="center" span="1"/>
              <col align="center" span="1"/>
              <col align="center" span="1"/>
              <col align="center" span="1"/>
            </colgroup>
            <thead>
              <tr>
                <td align="left" colspan="1" rowspan="1"/>
                <td align="left" colspan="1" rowspan="1"/>
                <td align="left" colspan="3" rowspan="1">Number of MBs</td>
              </tr>
              <tr>
                <td align="left" colspan="1" rowspan="1"/>
                <td align="left" colspan="1" rowspan="1"/>
                <td align="left" colspan="1" rowspan="1">Decrease (n = 11)</td>
                <td align="left" colspan="1" rowspan="1">No change (n = 24)</td>
                <td align="left" colspan="1" rowspan="1">Increase (n = 41)</td>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td align="left" colspan="1" rowspan="1">Demographic</td>
                <td align="left" colspan="1" rowspan="1">Gender (men)</td>
                <td align="left" colspan="1" rowspan="1">6 (54.5%)</td>
                <td align="left" colspan="1" rowspan="1">16 (66.7%)</td>
                <td align="left" colspan="1" rowspan="1">30 (73.2%)</td>
              </tr>
              <tr>
                <td align="left" colspan="1" rowspan="1"/>
                <td align="left" colspan="1" rowspan="1">Age, years</td>
                <td align="left" colspan="1" rowspan="1">61.1±13.5</td>
                <td align="left" colspan="1" rowspan="1">62.5±10.4</td>
                <td align="left" colspan="1" rowspan="1">66.6±11.4</td>
              </tr>
              <tr>
                <td align="left" colspan="1" rowspan="1"/>
                <td align="left" colspan="1" rowspan="1">Body mass index</td>
                <td align="left" colspan="1" rowspan="1">23.7±3.5</td>
                <td align="left" colspan="1" rowspan="1">24.2±2.5</td>
                <td align="left" colspan="1" rowspan="1">22.9±3.3</td>
              </tr>
              <tr>
                <td align="left" colspan="1" rowspan="1">Vascular risk factors</td>
                <td align="left" colspan="1" rowspan="1">Hypertension</td>
                <td align="left" colspan="1" rowspan="1">9 (81.8%)</td>
                <td align="left" colspan="1" rowspan="1">19 (79.2%)</td>
                <td align="left" colspan="1" rowspan="1">31 (75.6%)</td>
              </tr>
              <tr>
                <td align="left" colspan="1" rowspan="1"/>
                <td align="left" colspan="1" rowspan="1">Diabetes</td>
                <td align="left" colspan="1" rowspan="1">4 (36.4%)</td>
                <td align="left" colspan="1" rowspan="1">5 (20.8%)</td>
                <td align="left" colspan="1" rowspan="1">8 (19.5%)</td>
              </tr>
              <tr>
                <td align="left" colspan="1" rowspan="1"/>
                <td align="left" colspan="1" rowspan="1">Hyperlipidemia</td>
                <td align="left" colspan="1" rowspan="1">2 (18.2%)</td>
                <td align="left" colspan="1" rowspan="1">5 (20.8%)</td>
                <td align="left" colspan="1" rowspan="1">5 (12.2%)</td>
              </tr>
              <tr>
                <td align="left" colspan="1" rowspan="1"/>
                <td align="left" colspan="1" rowspan="1">Smoking</td>
                <td align="left" colspan="1" rowspan="1">4 (36.4%)</td>
                <td align="left" colspan="1" rowspan="1">4 (16.7%)</td>
                <td align="left" colspan="1" rowspan="1">8 (19.5%)</td>
              </tr>
              <tr>
                <td align="left" colspan="1" rowspan="1">Clinical profiles</td>
                <td align="left" colspan="1" rowspan="1">TIA</td>
                <td align="left" colspan="1" rowspan="1">0 (0%)</td>
                <td align="left" colspan="1" rowspan="1">4 (16.7%)</td>
                <td align="left" colspan="1" rowspan="1">5 (12.2%)</td>
              </tr>
              <tr>
                <td align="left" colspan="1" rowspan="1"/>
                <td align="left" colspan="1" rowspan="1">Stroke</td>
                <td align="left" colspan="1" rowspan="1">11 (100%)</td>
                <td align="left" colspan="1" rowspan="1">20 (83.3%)</td>
                <td align="left" colspan="1" rowspan="1">36 (87.4%)</td>
              </tr>
              <tr>
                <td align="left" colspan="1" rowspan="1"/>
                <td align="left" colspan="1" rowspan="1">NIHSS scores at baseline</td>
                <td align="left" colspan="1" rowspan="1">2.2±2.9</td>
                <td align="left" colspan="1" rowspan="1">2.4±1.9</td>
                <td align="left" colspan="1" rowspan="1">3.1±6.4</td>
              </tr>
              <tr>
                <td align="left" colspan="1" rowspan="1">Stroke subtypes</td>
                <td align="left" colspan="1" rowspan="1">Small vessel occlusion</td>
                <td align="left" colspan="1" rowspan="1">4 (36.4%)</td>
                <td align="left" colspan="1" rowspan="1">7 (29.2%)</td>
                <td align="left" colspan="1" rowspan="1">12 (29.3%)</td>
              </tr>
              <tr>
                <td align="left" colspan="1" rowspan="1"/>
                <td align="left" colspan="1" rowspan="1">Large artery atherosclerosis</td>
                <td align="left" colspan="1" rowspan="1">3 (27.3%)</td>
                <td align="left" colspan="1" rowspan="1">7 (29.2%)</td>
                <td align="left" colspan="1" rowspan="1">6 (14.6%)</td>
              </tr>
              <tr>
                <td align="left" colspan="1" rowspan="1"/>
                <td align="left" colspan="1" rowspan="1">Cardioembolism</td>
                <td align="left" colspan="1" rowspan="1">2 (18.2%)</td>
                <td align="left" colspan="1" rowspan="1">2 (8.3%)</td>
                <td align="left" colspan="1" rowspan="1">5 (12.2%)</td>
              </tr>
              <tr>
                <td align="left" colspan="1" rowspan="1"/>
                <td align="left" colspan="1" rowspan="1">UD or OD</td>
                <td align="left" colspan="1" rowspan="1">0 (0%)</td>
                <td align="left" colspan="1" rowspan="1">1 (4.2%)</td>
                <td align="left" colspan="1" rowspan="1">7 (17.1%)</td>
              </tr>
              <tr>
                <td align="left" colspan="1" rowspan="1"/>
                <td align="left" colspan="1" rowspan="1">Intracerebral hemorrhage</td>
                <td align="left" colspan="1" rowspan="1">2 (18.2%)</td>
                <td align="left" colspan="1" rowspan="1">3 (12.5%)</td>
                <td align="left" colspan="1" rowspan="1">6 (14.6%)</td>
              </tr>
            </tbody>
          </table></alternatives><table-wrap-foot>
            <fn id="nt104">
              <label/>
              <p>MB indicates microbleed; TIA, transient ischemic attack; NIHSS, National Institute of Health Stroke Scale; UD, undetermined; OD, other determined; ANOVA tests with Dunnett's post-hoc analysis or χ<sup>2</sup> tests were used, but there were no significant results.</p>
            </fn>
          </table-wrap-foot></table-wrap>
        <table-wrap id="pone-0025930-t003" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0025930.t003</object-id><label>Table 3</label><caption>
            <title>Baseline characteristics of patients according to temporal change of MBs counts during follow-up: part 2.</title>
          </caption><!--===== Grouping alternate versions of objects =====--><alternatives><graphic id="pone-0025930-t003-3" mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0025930.t003" xlink:type="simple"/><table>
            <colgroup span="1">
              <col align="left" span="1"/>
              <col align="center" span="1"/>
              <col align="center" span="1"/>
              <col align="center" span="1"/>
              <col align="center" span="1"/>
            </colgroup>
            <thead>
              <tr>
                <td align="left" colspan="1" rowspan="1"/>
                <td align="left" colspan="1" rowspan="1"/>
                <td align="left" colspan="3" rowspan="1">Number of MBs</td>
              </tr>
              <tr>
                <td align="left" colspan="1" rowspan="1"/>
                <td align="left" colspan="1" rowspan="1"/>
                <td align="left" colspan="1" rowspan="1">Decrease (n = 11)</td>
                <td align="left" colspan="1" rowspan="1">No change (n = 24)</td>
                <td align="left" colspan="1" rowspan="1">Increase (n = 41)</td>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td align="left" colspan="1" rowspan="1">Laboratory findings</td>
                <td align="left" colspan="1" rowspan="1">Total cholesterol, mg/dL<xref ref-type="table-fn" rid="nt108">†</xref></td>
                <td align="left" colspan="1" rowspan="1">201.7±31.7</td>
                <td align="left" colspan="1" rowspan="1">171.1±39.4</td>
                <td align="left" colspan="1" rowspan="1">179.7±40.0</td>
              </tr>
              <tr>
                <td align="left" colspan="1" rowspan="1"/>
                <td align="left" colspan="1" rowspan="1">LDL cholesterol, mg/dL<xref ref-type="table-fn" rid="nt107">*</xref><xref ref-type="table-fn" rid="nt108">†</xref></td>
                <td align="left" colspan="1" rowspan="1">133.5±23.5</td>
                <td align="left" colspan="1" rowspan="1">104.3±35.5</td>
                <td align="left" colspan="1" rowspan="1">102.8±31.7</td>
              </tr>
              <tr>
                <td align="left" colspan="1" rowspan="1"/>
                <td align="left" colspan="1" rowspan="1">HDL cholesterol, mg/dL</td>
                <td align="left" colspan="1" rowspan="1">41.6±7.2</td>
                <td align="left" colspan="1" rowspan="1">42.4±12.4</td>
                <td align="left" colspan="1" rowspan="1">41.3±12.7</td>
              </tr>
              <tr>
                <td align="left" colspan="1" rowspan="1"/>
                <td align="left" colspan="1" rowspan="1">Triglyceride, mg/dL</td>
                <td align="left" colspan="1" rowspan="1">138.0±70.3</td>
                <td align="left" colspan="1" rowspan="1">123.5±93.8</td>
                <td align="left" colspan="1" rowspan="1">132.4±98.4</td>
              </tr>
              <tr>
                <td align="left" colspan="1" rowspan="1"/>
                <td align="left" colspan="1" rowspan="1">Hemoglobin A1c, %</td>
                <td align="left" colspan="1" rowspan="1">6.5±1.2</td>
                <td align="left" colspan="1" rowspan="1">6.0±1.2</td>
                <td align="left" colspan="1" rowspan="1">6.0±1.3</td>
              </tr>
              <tr>
                <td align="left" colspan="1" rowspan="1"/>
                <td align="left" colspan="1" rowspan="1">Creatinine, mg/dL</td>
                <td align="left" colspan="1" rowspan="1">1.1±0.3</td>
                <td align="left" colspan="1" rowspan="1">1.1±0.5</td>
                <td align="left" colspan="1" rowspan="1">1.5±1.5</td>
              </tr>
              <tr>
                <td align="left" colspan="1" rowspan="1">Radiologic findings</td>
                <td align="left" colspan="1" rowspan="1">White matter lesions, grade</td>
                <td align="left" colspan="1" rowspan="1">2 (18.2%)</td>
                <td align="left" colspan="1" rowspan="1">4 (16.7%)</td>
                <td align="left" colspan="1" rowspan="1">7 (17.1%)</td>
              </tr>
              <tr>
                <td align="left" colspan="1" rowspan="1"/>
                <td align="left" colspan="1" rowspan="1">Grade 0</td>
                <td align="left" colspan="1" rowspan="1">2 (18.2%)</td>
                <td align="left" colspan="1" rowspan="1">14 (58.3%)</td>
                <td align="left" colspan="1" rowspan="1">13 (31.7%)</td>
              </tr>
              <tr>
                <td align="left" colspan="1" rowspan="1"/>
                <td align="left" colspan="1" rowspan="1">Grade 1<xref ref-type="table-fn" rid="nt108">†</xref><xref ref-type="table-fn" rid="nt109">§</xref></td>
                <td align="left" colspan="1" rowspan="1">4 (36.4%)</td>
                <td align="left" colspan="1" rowspan="1">5 (20.8%)</td>
                <td align="left" colspan="1" rowspan="1">10 (24.4%)</td>
              </tr>
              <tr>
                <td align="left" colspan="1" rowspan="1"/>
                <td align="left" colspan="1" rowspan="1">Grade 2</td>
                <td align="left" colspan="1" rowspan="1">3 (27.3%)</td>
                <td align="left" colspan="1" rowspan="1">1 (4.2%)</td>
                <td align="left" colspan="1" rowspan="1">11 (26.8%)</td>
              </tr>
              <tr>
                <td align="left" colspan="1" rowspan="1"/>
                <td align="left" colspan="1" rowspan="1">Grade 3<xref ref-type="table-fn" rid="nt108">†</xref><xref ref-type="table-fn" rid="nt109">§</xref></td>
                <td align="left" colspan="1" rowspan="1">2 (18.2%)</td>
                <td align="left" colspan="1" rowspan="1">4 (16.7%)</td>
                <td align="left" colspan="1" rowspan="1">7 (17.1%)</td>
              </tr>
              <tr>
                <td align="left" colspan="1" rowspan="1">Medications</td>
                <td align="left" colspan="1" rowspan="1">ACEIs/ARBs<xref ref-type="table-fn" rid="nt108">†</xref></td>
                <td align="left" colspan="1" rowspan="1">9 (81.8%)</td>
                <td align="left" colspan="1" rowspan="1">10 (41.7%)</td>
                <td align="left" colspan="1" rowspan="1">18 (43.9%)</td>
              </tr>
              <tr>
                <td align="left" colspan="1" rowspan="1"/>
                <td align="left" colspan="1" rowspan="1">CCBs</td>
                <td align="left" colspan="1" rowspan="1">4 (36.4%)</td>
                <td align="left" colspan="1" rowspan="1">6 (25.0%)</td>
                <td align="left" colspan="1" rowspan="1">7 (17.1%)</td>
              </tr>
              <tr>
                <td align="left" colspan="1" rowspan="1"/>
                <td align="left" colspan="1" rowspan="1">Beta-blockers</td>
                <td align="left" colspan="1" rowspan="1">2 (18.2%)</td>
                <td align="left" colspan="1" rowspan="1">6 (25.0%)</td>
                <td align="left" colspan="1" rowspan="1">10 (24.4%)</td>
              </tr>
              <tr>
                <td align="left" colspan="1" rowspan="1"/>
                <td align="left" colspan="1" rowspan="1">Diuretics</td>
                <td align="left" colspan="1" rowspan="1">7 (63.6%)</td>
                <td align="left" colspan="1" rowspan="1">14 (58.3%)</td>
                <td align="left" colspan="1" rowspan="1">10 (24.4%)</td>
              </tr>
              <tr>
                <td align="left" colspan="1" rowspan="1"/>
                <td align="left" colspan="1" rowspan="1">Statins</td>
                <td align="left" colspan="1" rowspan="1">4 (36.4%)</td>
                <td align="left" colspan="1" rowspan="1">6 (25.0%)</td>
                <td align="left" colspan="1" rowspan="1">12 (29.3%)</td>
              </tr>
              <tr>
                <td align="left" colspan="1" rowspan="1"/>
                <td align="left" colspan="1" rowspan="1">Antiplatelet agents</td>
                <td align="left" colspan="1" rowspan="1">6 (54.5%)</td>
                <td align="left" colspan="1" rowspan="1">19 (79.2%)</td>
                <td align="left" colspan="1" rowspan="1">29 (70.7%)</td>
              </tr>
              <tr>
                <td align="left" colspan="1" rowspan="1"/>
                <td align="left" colspan="1" rowspan="1">Anticoagulation</td>
                <td align="left" colspan="1" rowspan="1">2 (18.2%)</td>
                <td align="left" colspan="1" rowspan="1">2 (8.3%)</td>
                <td align="left" colspan="1" rowspan="1">8 (19.5%)</td>
              </tr>
              <tr>
                <td align="left" colspan="1" rowspan="1"/>
                <td align="left" colspan="1" rowspan="1">Oral hypoglycemic agents</td>
                <td align="left" colspan="1" rowspan="1">2 (18.2%)</td>
                <td align="left" colspan="1" rowspan="1">3 (12.5%)</td>
                <td align="left" colspan="1" rowspan="1">4 (9.8%)</td>
              </tr>
            </tbody>
          </table></alternatives><table-wrap-foot>
            <fn id="nt105">
              <label/>
              <p>LDL indicates low-density lipoprotein; HDL, high-density lipoprotein; ACEI, angiotensin-converting enzyme inhibitor; ARB, angiotensin-receptor blocker.</p>
            </fn>
            <fn id="nt106">
              <label/>
              <p>ANOVA tests with Dunnett's post-hoc analysis or χ<sup>2</sup> tests were used:</p>
            </fn>
            <fn id="nt107">
              <label/>
              <p>*indicates <italic>p</italic>&lt;0.05 from overall comparisons;</p>
            </fn>
            <fn id="nt108">
              <label>†</label>
              <p>, <italic>p</italic>&lt;0.05 from post-hoc analysis between “decreased” and “no change”;</p>
            </fn>
            <fn id="nt109">
              <label>§</label>
              <p>, <italic>p</italic>&lt;0.05 from post-hoc analysis between “increased” and “no change”.</p>
            </fn>
          </table-wrap-foot></table-wrap>
        <p>Estimated annual change rates of MB numbers are revealed in <xref ref-type="table" rid="pone-0025930-t004">Table 4</xref>. The rate of increase in the number of MBs was about 0.8 lesions per year in all patients, a value which increased when we restricted our analysis only to those patients with MBs at baseline. The rate of increase in patients without MB at baseline was very small (0.04 lesions per year).</p>
        <table-wrap id="pone-0025930-t004" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0025930.t004</object-id><label>Table 4</label><caption>
            <title>Estimated annual rates of change of MB counts.</title>
          </caption><!--===== Grouping alternate versions of objects =====--><alternatives><graphic id="pone-0025930-t004-4" mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0025930.t004" xlink:type="simple"/><table>
            <colgroup span="1">
              <col align="left" span="1"/>
              <col align="center" span="1"/>
            </colgroup>
            <thead>
              <tr>
                <td align="left" colspan="1" rowspan="1">Patients</td>
                <td align="left" colspan="1" rowspan="1">Annual rate of change of MB counts (lesions per year)</td>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td align="left" colspan="1" rowspan="1">Total patients (n = 224)</td>
                <td align="left" colspan="1" rowspan="1">0.80±3.80</td>
              </tr>
              <tr>
                <td align="left" colspan="1" rowspan="1">MBs at baseline = 0 (n = 148)</td>
                <td align="left" colspan="1" rowspan="1">0.04±0.14</td>
              </tr>
              <tr>
                <td align="left" colspan="1" rowspan="1">MBs at baseline≥1 (n = 76)</td>
                <td align="left" colspan="1" rowspan="1">2.30±6.28</td>
              </tr>
              <tr>
                <td align="left" colspan="1" rowspan="1">MBs at baseline≥2 (n = 55)</td>
                <td align="left" colspan="1" rowspan="1">3.00±7.25</td>
              </tr>
              <tr>
                <td align="left" colspan="1" rowspan="1">MBs at baseline≥5 (n = 28)</td>
                <td align="left" colspan="1" rowspan="1">5.43±9.59</td>
              </tr>
            </tbody>
          </table></alternatives><table-wrap-foot>
            <fn id="nt110">
              <label/>
              <p>MB indicates microbleed.</p>
            </fn>
          </table-wrap-foot></table-wrap>
      </sec>
      <sec id="s3e">
        <title>Predictors of temporal changes of MBs</title>
        <p>We used the GEE models to find predictors of temporal changes of MBs. Based on the univariable analyses, age and grades of white matter lesions were identified as predictors for increasing MB count, and diabetes, hyperlipidemia, the highest quartile of LDL-cholesterol, and the highest quartile of triglyceride during the follow-up period were documented as predictors for decreasing number of MBs (<xref ref-type="table" rid="pone-0025930-t005">Table 5</xref>). Compared to stroke due to other types or transient ischemic attack, it was determined that small vessel occlusion and intracerebral hemorrhage were strongly associated with MB count. Based on the multivariable analyses performed to identify predictor variables for MB count over time, strokes due to small vessel occlusion and intracerebral hemorrhage, the highest quartile of LDL-cholesterol, and white matter lesions were determined to be independently associated with MB count (<xref ref-type="table" rid="pone-0025930-t006">Table 6</xref>).</p>
        <table-wrap id="pone-0025930-t005" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0025930.t005</object-id><label>Table 5</label><caption>
            <title>Univariable analysis using the GEE model.</title>
          </caption><!--===== Grouping alternate versions of objects =====--><alternatives><graphic id="pone-0025930-t005-5" mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0025930.t005" xlink:type="simple"/><table>
            <colgroup span="1">
              <col align="left" span="1"/>
              <col align="center" span="1"/>
              <col align="center" span="1"/>
            </colgroup>
            <thead>
              <tr>
                <td align="left" colspan="1" rowspan="1"/>
                <td align="left" colspan="1" rowspan="1">Crude RR</td>
                <td align="left" colspan="1" rowspan="1">95% CI</td>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td align="left" colspan="1" rowspan="1">Gender (men)</td>
                <td align="left" colspan="1" rowspan="1">1.21</td>
                <td align="left" colspan="1" rowspan="1">0.53–2.77</td>
              </tr>
              <tr>
                <td align="left" colspan="1" rowspan="1">Age (per 1-year increase)</td>
                <td align="left" colspan="1" rowspan="1">1.04</td>
                <td align="left" colspan="1" rowspan="1">1.01–1.07</td>
              </tr>
              <tr>
                <td align="left" colspan="1" rowspan="1">Body mass index (per 1-kg/m<sup>2</sup> increase)</td>
                <td align="left" colspan="1" rowspan="1">0.97</td>
                <td align="left" colspan="1" rowspan="1">0.85–1.12</td>
              </tr>
              <tr>
                <td align="left" colspan="1" rowspan="1">Hypertension</td>
                <td align="left" colspan="1" rowspan="1">1.67</td>
                <td align="left" colspan="1" rowspan="1">0.52–5.29</td>
              </tr>
              <tr>
                <td align="left" colspan="1" rowspan="1">Diabetes</td>
                <td align="left" colspan="1" rowspan="1">0.32</td>
                <td align="left" colspan="1" rowspan="1">0.13–0.76</td>
              </tr>
              <tr>
                <td align="left" colspan="1" rowspan="1">Hyperlipidemia</td>
                <td align="left" colspan="1" rowspan="1">0.35</td>
                <td align="left" colspan="1" rowspan="1">0.13–0.97</td>
              </tr>
              <tr>
                <td align="left" colspan="1" rowspan="1">Smoking</td>
                <td align="left" colspan="1" rowspan="1">0.79</td>
                <td align="left" colspan="1" rowspan="1">0.22–2.86</td>
              </tr>
              <tr>
                <td align="left" colspan="1" rowspan="1">Small vessel occlusion</td>
                <td align="left" colspan="1" rowspan="1">2.77</td>
                <td align="left" colspan="1" rowspan="1">1.15–6.68</td>
              </tr>
              <tr>
                <td align="left" colspan="1" rowspan="1">Intracerebral hemorrhage</td>
                <td align="left" colspan="1" rowspan="1">4.72</td>
                <td align="left" colspan="1" rowspan="1">1.61–13.84</td>
              </tr>
              <tr>
                <td align="left" colspan="1" rowspan="1">NIHSS at admission (per 1-point increase)</td>
                <td align="left" colspan="1" rowspan="1">0.99</td>
                <td align="left" colspan="1" rowspan="1">0.89–1.10</td>
              </tr>
              <tr>
                <td align="left" colspan="1" rowspan="1">Total cholesterol (4th quartile vs. others)</td>
                <td align="left" colspan="1" rowspan="1">0.27</td>
                <td align="left" colspan="1" rowspan="1">0.13–0.55</td>
              </tr>
              <tr>
                <td align="left" colspan="1" rowspan="1">LDL-cholesterol (4th quartile vs. others)</td>
                <td align="left" colspan="1" rowspan="1">0.23</td>
                <td align="left" colspan="1" rowspan="1">0.11–0.49</td>
              </tr>
              <tr>
                <td align="left" colspan="1" rowspan="1">HDL-cholesterol (1st quartile vs. others)</td>
                <td align="left" colspan="1" rowspan="1">1.14</td>
                <td align="left" colspan="1" rowspan="1">0.40–3.23</td>
              </tr>
              <tr>
                <td align="left" colspan="1" rowspan="1">Triglyceride (4th quartile vs. others)</td>
                <td align="left" colspan="1" rowspan="1">0.18</td>
                <td align="left" colspan="1" rowspan="1">0.09–0.37</td>
              </tr>
              <tr>
                <td align="left" colspan="1" rowspan="1">Hemoglobin A1c (per 1% increase)</td>
                <td align="left" colspan="1" rowspan="1">0.79</td>
                <td align="left" colspan="1" rowspan="1">0.67–0.94</td>
              </tr>
              <tr>
                <td align="left" colspan="1" rowspan="1">Creatinine (per 1 mg/dL increase)</td>
                <td align="left" colspan="1" rowspan="1">1.00</td>
                <td align="left" colspan="1" rowspan="1">0.86–1.17</td>
              </tr>
              <tr>
                <td align="left" colspan="1" rowspan="1">White matter lesions (per 1-grade increase)</td>
                <td align="left" colspan="1" rowspan="1">2.78</td>
                <td align="left" colspan="1" rowspan="1">1.62–4.78</td>
              </tr>
              <tr>
                <td align="left" colspan="1" rowspan="1">ACEIs or ARBs</td>
                <td align="left" colspan="1" rowspan="1">1.17</td>
                <td align="left" colspan="1" rowspan="1">0.50–2.73</td>
              </tr>
              <tr>
                <td align="left" colspan="1" rowspan="1">CCBs</td>
                <td align="left" colspan="1" rowspan="1">0.71</td>
                <td align="left" colspan="1" rowspan="1">0.32–1.56</td>
              </tr>
              <tr>
                <td align="left" colspan="1" rowspan="1">Beta-blockers</td>
                <td align="left" colspan="1" rowspan="1">1.77</td>
                <td align="left" colspan="1" rowspan="1">0.68–4.60</td>
              </tr>
              <tr>
                <td align="left" colspan="1" rowspan="1">Diuretics</td>
                <td align="left" colspan="1" rowspan="1">1.30</td>
                <td align="left" colspan="1" rowspan="1">0.44–3.83</td>
              </tr>
              <tr>
                <td align="left" colspan="1" rowspan="1">Statins</td>
                <td align="left" colspan="1" rowspan="1">0.90</td>
                <td align="left" colspan="1" rowspan="1">0.32–2.56</td>
              </tr>
              <tr>
                <td align="left" colspan="1" rowspan="1">Antiplatelet agents</td>
                <td align="left" colspan="1" rowspan="1">0.81</td>
                <td align="left" colspan="1" rowspan="1">0.33–2.01</td>
              </tr>
              <tr>
                <td align="left" colspan="1" rowspan="1">Anticoagulation</td>
                <td align="left" colspan="1" rowspan="1">0.60</td>
                <td align="left" colspan="1" rowspan="1">0.23–1.57</td>
              </tr>
            </tbody>
          </table></alternatives><table-wrap-foot>
            <fn id="nt111">
              <label/>
              <p>GEE indicates generalized estimating equations; RR, rate ratio; CI, confidence interval; NIHSS, National Institute of Health Stroke Scale; LDL, low-density lipoprotein; HDL, high-density lipoprotein; ACEI, angiotensin-converting enzyme inhibitor; ARB, angiotensin-receptor blocker.</p>
            </fn>
          </table-wrap-foot></table-wrap>
        <table-wrap id="pone-0025930-t006" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0025930.t006</object-id><label>Table 6</label><caption>
            <title>Multivariable analysis using the GEE model.</title>
          </caption><!--===== Grouping alternate versions of objects =====--><alternatives><graphic id="pone-0025930-t006-6" mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0025930.t006" xlink:type="simple"/><table>
            <colgroup span="1">
              <col align="left" span="1"/>
              <col align="center" span="1"/>
              <col align="center" span="1"/>
            </colgroup>
            <thead>
              <tr>
                <td align="left" colspan="1" rowspan="1"/>
                <td align="left" colspan="1" rowspan="1">Adjusted RR</td>
                <td align="left" colspan="1" rowspan="1">95% CI</td>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td align="left" colspan="1" rowspan="1">Small vessel occlusion</td>
                <td align="left" colspan="1" rowspan="1">2.49</td>
                <td align="left" colspan="1" rowspan="1">1.15–5.40</td>
              </tr>
              <tr>
                <td align="left" colspan="1" rowspan="1">Intracerebral hemorrhage</td>
                <td align="left" colspan="1" rowspan="1">4.06</td>
                <td align="left" colspan="1" rowspan="1">1.01–16.32</td>
              </tr>
              <tr>
                <td align="left" colspan="1" rowspan="1">LDL-cholesterol (4<sup>th</sup> quartile vs others)</td>
                <td align="left" colspan="1" rowspan="1">0.30</td>
                <td align="left" colspan="1" rowspan="1">0.14–0.68</td>
              </tr>
              <tr>
                <td align="left" colspan="1" rowspan="1">White matter lesions (per 1-grade increase)</td>
                <td align="left" colspan="1" rowspan="1">2.39</td>
                <td align="left" colspan="1" rowspan="1">1.27–4.53</td>
              </tr>
            </tbody>
          </table></alternatives></table-wrap>
      </sec>
    </sec>
    <sec id="s4">
      <title>Discussion</title>
      <p>In this follow-up study, we found that temporal change in MB counts was dynamic with the total number of MBs increasing by 1.5-fold over time. The rate of change in MB counts was 0.80 lesions per year in all patients, and became much greater in patients with MBs at baseline. Specifically, this increasing trend was about 60-fold greater in patients with MBs at baseline than in patients without. Additionally, the presence of diabetes was negatively associated with the presence of MBs at baseline, whereas severity of white matter lesions was a strong risk factor. With regard to the change in MB counts during follow-up, strokes due to small vessel occlusion and intracerebral hemorrhage and white matter lesions were identified as independent risk factors, whereas the highest quartile of LDL cholesterol was identified as an independent protective factor.</p>
      <p>MBs are closely associated with incident or recurrent intracerebral hemorrhage among the stroke subtypes, and it has been noted that the presence or number of MBs is the most important radiologic marker of a cerebral bleeding tendency due to small vessel disease <xref ref-type="bibr" rid="pone.0025930-Greenberg1">[1]</xref>, <xref ref-type="bibr" rid="pone.0025930-Greenberg3">[16]</xref>, <xref ref-type="bibr" rid="pone.0025930-Roob2">[17]</xref>. However, long-term temporal change of lesions in the elderly has rarely been reported. A recent report examined 21 patients with ischemic stroke or TIA over an average of 5.5 years <xref ref-type="bibr" rid="pone.0025930-Gregoire1">[18]</xref>. Their results showed that those with new MBs represented 50% of the patients with MBs at baseline (4 out of 8 patients); however, only 8% of patients without (1 out of 13 patients). In the present study, we showed that new MBs were found in 53.9% of patients with MBs at baseline (41 out of 76 patients), but only in 6.8% of patients without (10 out of 148 patients). Considering a follow-up period of 27 months, the current results regarding temporal change of MBs after ischemic stroke or TIA are in line with previous studies. Additionally, the great discrepancy regarding the increased incidence of MBs in patients with MBs at baseline as compared to those without MBs is very similar to the results from the PROGRESS MRI sub-study on temporal change of white matter lesions after ischemic stroke <xref ref-type="bibr" rid="pone.0025930-Dufouil1">[19]</xref>. Ischemic stroke and TIA are frequently found in elderly people, and share substantial pathophysiological mechanisms although representing two different aspects of small vessel disease (ischemia vs. hemorrhage) <xref ref-type="bibr" rid="pone.0025930-Inzitari1">[20]</xref>, <xref ref-type="bibr" rid="pone.0025930-Fazekas2">[21]</xref>. Results both from our study and the PROGRESS sub-study demonstrate that presence of small vessel disease at baseline itself may be crucial in progress of the small vessel disease <xref ref-type="bibr" rid="pone.0025930-Dufouil1">[19]</xref>. Our results suggest that in patients with even a single MB, caution should be taken in their management, with special attention paid to the incidence of intracerebral hemorrhage.</p>
      <p>We and others have previously shown that low concentrations of serum cholesterol are associated with the severe MBs, suggesting the antagonizing role of cholesterol in MB pathogenesis <xref ref-type="bibr" rid="pone.0025930-Lee2">[5]</xref>, <xref ref-type="bibr" rid="pone.0025930-Vernooij1">[22]</xref>. In the present study, we found that the highest quartile of LDL cholesterol was independently associated with a decrease in MB counts during the follow-up. In fact, many large cohort studies have demonstrated that low serum levels of total cholesterol may represent a risk factor for intracerebral hemorrhage, especially in Japan <xref ref-type="bibr" rid="pone.0025930-Tanaka2">[23]</xref>, <xref ref-type="bibr" rid="pone.0025930-Yano1">[24]</xref>, <xref ref-type="bibr" rid="pone.0025930-Konishi1">[25]</xref>, <xref ref-type="bibr" rid="pone.0025930-Ueda1">[26]</xref>. A similar inverse relationship was reported between serum total cholesterol level and the risk of death from hemorrhagic stroke in western countries <xref ref-type="bibr" rid="pone.0025930-Iso1">[27]</xref>. Considering the pathology of MB (hemosiderin pigment accumulations in macrophages adjacent to the ruptured atherosclerotic microvessels) <xref ref-type="bibr" rid="pone.0025930-Fazekas2">[21]</xref>, the disappearance of MBs might depend on the clearance of hemosiderin-containing macrophages. Because MBs are frequently associated with microaneurysms <xref ref-type="bibr" rid="pone.0025930-Tatsumi1">[28]</xref>, any changes related to hemosiderin-containing microaneurysms may be associated as well. It was hypothesized that high levels of LDL cholesterol were likely to prevent small vessel rupture in the brain <xref ref-type="bibr" rid="pone.0025930-Lee2">[5]</xref>, <xref ref-type="bibr" rid="pone.0025930-Reed1">[29]</xref>, <xref ref-type="bibr" rid="pone.0025930-Yamori1">[30]</xref>; however, there has been no evidence that high level of LDL cholesterol can enhance the clearance of hemosiderin-containing microglia. Taken together, these hypotheses warrant further confirmation studies.</p>
      <p>Despite the accumulation of evidence on cholesterol and bleeding, association between the use of lipid-lowering therapy such as statin and the occurrence of cerebral bleeding episodes has been controversial. Only one report has indicated that intensive lipid-lowering after stroke significantly increased the incidence of intracerebral hemorrhage <xref ref-type="bibr" rid="pone.0025930-Amarenco1">[31]</xref>, whereas other statin studies have produced contradictory. While many issues exist (primary or secondary prevention of stroke, stroke subtypes, and risk factor burden, etc), systematic reviews on this topic show inconsistent conclusions <xref ref-type="bibr" rid="pone.0025930-Vergouwen1">[32]</xref>, <xref ref-type="bibr" rid="pone.0025930-Amarenco2">[33]</xref>. Therefore, the effects of low levels of LDL cholesterol on the brain should be further investigated in terms of the nature of the low level - intrinsic low level vs. low level therapeutically intervened by statin.</p>
      <p>This study clearly demonstrated an association between small vessel occlusion and intracerebral hemorrhage as baseline stroke subtypes with an increase in MB counts. This result confirms that MBs are produced by advanced cerebral small vessel disease <xref ref-type="bibr" rid="pone.0025930-Lee5">[10]</xref>, <xref ref-type="bibr" rid="pone.0025930-Fazekas2">[21]</xref>. Moreover, an association with small vessel occlusion, that is lacunar infarction, indicates caution should be taken with intensive long-term anti-thrombotic therapy in such patients.</p>
      <p>There are some caveats to this study. First, in general, diabetes is not a risk factor for intracerebral hemorrhage <xref ref-type="bibr" rid="pone.0025930-Qureshi1">[34]</xref>. In this study, the presence of diabetes was a protective factor for presence of MBs at baseline, but this association was not replicated in the follow-up analysis. It has been reported that diabetes tends to increase large artery atherosclerosis rather than small vessel occlusion <xref ref-type="bibr" rid="pone.0025930-Rothwell1">[35]</xref>, <xref ref-type="bibr" rid="pone.0025930-Kim1">[36]</xref>; however, this suggestion was not supported here. The biological effects of diabetes on the brain vascular system need to be clarified. Second, from the initial population, 90 patients expired and thus, a suitable follow-up was not possible. It is possible that the deceased patients may have demonstrated a greater change in MB count than those patients that lived through the follow-up period. If we had performed frequent brain MRIs, we would have shown more a precise temporal course; however, this study design did not allow for that due to ethical and economical considerations. Thus, our study results may be interpreted for surviving patients during the follow up period after ischemic stroke and TIA.</p>
      <p>Our results showed that long-term temporal change of MBs after ischemic stroke is dynamic, and that this dynamicity is largely affected by the initial appearance of MBs. Further, changes in MB count may be associated with small vessel disease and the level of LDL cholesterol. Our results provide an effective basis for further MB studies. Recent recognition of the effect of MB on cognitive decline indicates that MBs are no longer a “silent” lesion. Thus, dynamic changes in MB counts should be further investigated in terms of their effects on cognitive function as well as on other vascular events.</p>
    </sec>
  </body>
  <back>
    <ref-list>
      <title>References</title>
      <ref id="pone.0025930-Greenberg1">
        <label>1</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Greenberg</surname><given-names>SM</given-names></name><name name-style="western"><surname>Vernooij</surname><given-names>MW</given-names></name><name name-style="western"><surname>Cordonnier</surname><given-names>C</given-names></name><name name-style="western"><surname>Viswanathan</surname><given-names>A</given-names></name><name name-style="western"><surname>Al-Shahi Salman</surname><given-names>R</given-names></name><etal/></person-group>             <year>2009</year>             <article-title>Cerebral microbleeds: a guide to detection and interpretation.</article-title>             <source>Lancet Neurol</source>             <volume>8</volume>             <fpage>165</fpage>             <lpage>174</lpage>          </element-citation>
      </ref>
      <ref id="pone.0025930-Roob1">
        <label>2</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Roob</surname><given-names>G</given-names></name><name name-style="western"><surname>Schmidt</surname><given-names>R</given-names></name><name name-style="western"><surname>Kapeller</surname><given-names>P</given-names></name><name name-style="western"><surname>Lechner</surname><given-names>A</given-names></name><name name-style="western"><surname>Hartung</surname><given-names>HP</given-names></name><etal/></person-group>             <year>1999</year>             <article-title>MRI evidence of past cerebral microbleeds in a healthy elderly population.</article-title>             <source>Neurology</source>             <volume>52</volume>             <fpage>991</fpage>             <lpage>994</lpage>          </element-citation>
      </ref>
      <ref id="pone.0025930-Tanaka1">
        <label>3</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Tanaka</surname><given-names>A</given-names></name><name name-style="western"><surname>Ueno</surname><given-names>Y</given-names></name><name name-style="western"><surname>Nakayama</surname><given-names>Y</given-names></name><name name-style="western"><surname>Takano</surname><given-names>K</given-names></name><name name-style="western"><surname>Takebayashi</surname><given-names>S</given-names></name></person-group>             <year>1999</year>             <article-title>Small chronic hemorrhages and ischemic lesions in association with spontaneous intracerebral hematomas.</article-title>             <source>Stroke</source>             <volume>30</volume>             <fpage>1637</fpage>             <lpage>1642</lpage>          </element-citation>
      </ref>
      <ref id="pone.0025930-Lee1">
        <label>4</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Lee</surname><given-names>SH</given-names></name><name name-style="western"><surname>Park</surname><given-names>JM</given-names></name><name name-style="western"><surname>Kwon</surname><given-names>SJ</given-names></name><name name-style="western"><surname>Kim</surname><given-names>H</given-names></name><name name-style="western"><surname>Kim</surname><given-names>YH</given-names></name><etal/></person-group>             <year>2004</year>             <article-title>Left ventricular hypertrophy is associated with cerebral microbleeds in hypertensive patients.</article-title>             <source>Neurology</source>             <volume>63</volume>             <fpage>16</fpage>             <lpage>21</lpage>          </element-citation>
      </ref>
      <ref id="pone.0025930-Lee2">
        <label>5</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Lee</surname><given-names>SH</given-names></name><name name-style="western"><surname>Bae</surname><given-names>HJ</given-names></name><name name-style="western"><surname>Yoon</surname><given-names>BW</given-names></name><name name-style="western"><surname>Kim</surname><given-names>H</given-names></name><name name-style="western"><surname>Kim</surname><given-names>DE</given-names></name><etal/></person-group>             <year>2002</year>             <article-title>Low concentration of serum total cholesterol is associated with multifocal signal loss lesions on gradient-echo magnetic resonance imaging: analysis of risk factors for multifocal signal loss lesions.</article-title>             <source>Stroke</source>             <volume>33</volume>             <fpage>2845</fpage>             <lpage>2849</lpage>          </element-citation>
      </ref>
      <ref id="pone.0025930-Greenberg2">
        <label>6</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Greenberg</surname><given-names>SM</given-names></name><name name-style="western"><surname>O'Donnell</surname><given-names>HC</given-names></name><name name-style="western"><surname>Schaefer</surname><given-names>PW</given-names></name><name name-style="western"><surname>Kraft</surname><given-names>E</given-names></name></person-group>             <year>1999</year>             <article-title>MRI detection of new hemorrhages: potential marker of progression in cerebral amyloid angiopathy.</article-title>             <source>Neurology</source>             <volume>53</volume>             <fpage>1135</fpage>             <lpage>1138</lpage>          </element-citation>
      </ref>
      <ref id="pone.0025930-Lee3">
        <label>7</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Lee</surname><given-names>SH</given-names></name><name name-style="western"><surname>Bae</surname><given-names>HJ</given-names></name><name name-style="western"><surname>Kwon</surname><given-names>SJ</given-names></name><name name-style="western"><surname>Kim</surname><given-names>H</given-names></name><name name-style="western"><surname>Kim</surname><given-names>YH</given-names></name><etal/></person-group>             <year>2004</year>             <article-title>Cerebral microbleeds are regionally associated with intracerebral hemorrhage.</article-title>             <source>Neurology</source>             <volume>62</volume>             <fpage>72</fpage>             <lpage>76</lpage>          </element-citation>
      </ref>
      <ref id="pone.0025930-Wong1">
        <label>8</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Wong</surname><given-names>KS</given-names></name><name name-style="western"><surname>Chan</surname><given-names>YL</given-names></name><name name-style="western"><surname>Liu</surname><given-names>JY</given-names></name><name name-style="western"><surname>Gao</surname><given-names>S</given-names></name><name name-style="western"><surname>Lam</surname><given-names>WW</given-names></name></person-group>             <year>2003</year>             <article-title>Asymptomatic microbleeds as a risk factor for aspirin-associated intracerebral hemorrhages.</article-title>             <source>Neurology</source>             <volume>60</volume>             <fpage>511</fpage>             <lpage>513</lpage>          </element-citation>
      </ref>
      <ref id="pone.0025930-Lee4">
        <label>9</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Lee</surname><given-names>SH</given-names></name><name name-style="western"><surname>Ryu</surname><given-names>WS</given-names></name><name name-style="western"><surname>Roh</surname><given-names>JK</given-names></name></person-group>             <year>2009</year>             <article-title>Cerebral microbleeds are a risk factor for warfarin-related intracerebral hemorrhage.</article-title>             <source>Neurology</source>             <volume>72</volume>             <fpage>171</fpage>             <lpage>176</lpage>          </element-citation>
      </ref>
      <ref id="pone.0025930-Lee5">
        <label>10</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Lee</surname><given-names>SH</given-names></name><name name-style="western"><surname>Bae</surname><given-names>HJ</given-names></name><name name-style="western"><surname>Ko</surname><given-names>SB</given-names></name><name name-style="western"><surname>Kim</surname><given-names>H</given-names></name><name name-style="western"><surname>Yoon</surname><given-names>BW</given-names></name><etal/></person-group>             <year>2004</year>             <article-title>Comparative analysis of the spatial distribution and severity of cerebral microbleeds and old lacunes.</article-title>             <source>J Neurol Neurosurg Psychiatry</source>             <volume>75</volume>             <fpage>423</fpage>             <lpage>427</lpage>          </element-citation>
      </ref>
      <ref id="pone.0025930-Henneman1">
        <label>11</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Henneman</surname><given-names>WJ</given-names></name><name name-style="western"><surname>Sluimer</surname><given-names>JD</given-names></name><name name-style="western"><surname>Cordonnier</surname><given-names>C</given-names></name><name name-style="western"><surname>Baak</surname><given-names>MM</given-names></name><name name-style="western"><surname>Scheltens</surname><given-names>P</given-names></name><etal/></person-group>             <year>2009</year>             <article-title>MRI biomarkers of vascular damage and atrophy predicting mortality in a memory clinic population.</article-title>             <source>Stroke</source>             <volume>40</volume>             <fpage>492</fpage>             <lpage>498</lpage>          </element-citation>
      </ref>
      <ref id="pone.0025930-Jee1">
        <label>12</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Jee</surname><given-names>SH</given-names></name><name name-style="western"><surname>Sull</surname><given-names>JW</given-names></name><name name-style="western"><surname>Park</surname><given-names>J</given-names></name><name name-style="western"><surname>Lee</surname><given-names>SY</given-names></name><name name-style="western"><surname>Ohrr</surname><given-names>H</given-names></name><etal/></person-group>             <year>2006</year>             <article-title>Body-mass index and mortality in Korean men and women.</article-title>             <source>N Engl J Med</source>             <volume>355</volume>             <fpage>779</fpage>             <lpage>787</lpage>          </element-citation>
      </ref>
      <ref id="pone.0025930-Adams1">
        <label>13</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Adams</surname><given-names>HP</given-names><suffix>Jr</suffix></name><name name-style="western"><surname>Bendixen</surname><given-names>BH</given-names></name><name name-style="western"><surname>Kappelle</surname><given-names>LJ</given-names></name><name name-style="western"><surname>Biller</surname><given-names>J</given-names></name><name name-style="western"><surname>Love</surname><given-names>BB</given-names></name><etal/></person-group>             <year>1993</year>             <article-title>Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment.</article-title>             <source>Stroke</source>             <volume>24</volume>             <fpage>35</fpage>             <lpage>41</lpage>          </element-citation>
      </ref>
      <ref id="pone.0025930-Fazekas1">
        <label>14</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Fazekas</surname><given-names>F</given-names></name><name name-style="western"><surname>Chawluk</surname><given-names>JB</given-names></name><name name-style="western"><surname>Alavi</surname><given-names>A</given-names></name><name name-style="western"><surname>Hurtig</surname><given-names>HI</given-names></name><name name-style="western"><surname>Zimmerman</surname><given-names>RA</given-names></name></person-group>             <year>1987</year>             <article-title>MR signal abnormalities at 1.5 T in Alzheimer's dementia and normal aging.</article-title>             <source>AJR Am J Roentgenol</source>             <volume>149</volume>             <fpage>351</fpage>             <lpage>356</lpage>          </element-citation>
      </ref>
      <ref id="pone.0025930-Zeger1">
        <label>15</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Zeger</surname><given-names>SL</given-names></name><name name-style="western"><surname>Liang</surname><given-names>KY</given-names></name></person-group>             <year>1986</year>             <article-title>Longitudinal data analysis for discrete and continuous outcomes.</article-title>             <source>Biometrics</source>             <volume>42</volume>             <fpage>121</fpage>             <lpage>130</lpage>          </element-citation>
      </ref>
      <ref id="pone.0025930-Greenberg3">
        <label>16</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Greenberg</surname><given-names>SM</given-names></name><name name-style="western"><surname>Eng</surname><given-names>JA</given-names></name><name name-style="western"><surname>Ning</surname><given-names>M</given-names></name><name name-style="western"><surname>Smith</surname><given-names>EE</given-names></name><name name-style="western"><surname>Rosand</surname><given-names>J</given-names></name></person-group>             <year>2004</year>             <article-title>Hemorrhage burden predicts recurrent intracerebral hemorrhage after lobar hemorrhage.</article-title>             <source>Stroke</source>             <volume>35</volume>             <fpage>1415</fpage>             <lpage>1420</lpage>          </element-citation>
      </ref>
      <ref id="pone.0025930-Roob2">
        <label>17</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Roob</surname><given-names>G</given-names></name><name name-style="western"><surname>Fazekas</surname><given-names>F</given-names></name></person-group>             <year>2000</year>             <article-title>Magnetic resonance imaging of cerebral microbleeds.</article-title>             <source>Curr Opin Neurol</source>             <volume>13</volume>             <fpage>69</fpage>             <lpage>73</lpage>          </element-citation>
      </ref>
      <ref id="pone.0025930-Gregoire1">
        <label>18</label>
        <element-citation publication-type="other" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Gregoire</surname><given-names>SM</given-names></name><name name-style="western"><surname>Brown</surname><given-names>MM</given-names></name><name name-style="western"><surname>Kallis</surname><given-names>C</given-names></name><name name-style="western"><surname>Jager</surname><given-names>HR</given-names></name><name name-style="western"><surname>Yousry</surname><given-names>TA</given-names></name><etal/></person-group>             <year>2009</year>             <article-title>MRI Detection of New Microbleeds in Patients With Ischemic Stroke.</article-title>             <comment>Five-Year Cohort Follow-Up Study. Stroke</comment>          </element-citation>
      </ref>
      <ref id="pone.0025930-Dufouil1">
        <label>19</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Dufouil</surname><given-names>C</given-names></name><name name-style="western"><surname>Chalmers</surname><given-names>J</given-names></name><name name-style="western"><surname>Coskun</surname><given-names>O</given-names></name><name name-style="western"><surname>Besancon</surname><given-names>V</given-names></name><name name-style="western"><surname>Bousser</surname><given-names>MG</given-names></name><etal/></person-group>             <year>2005</year>             <article-title>Effects of blood pressure lowering on cerebral white matter hyperintensities in patients with stroke: the PROGRESS (Perindopril Protection Against Recurrent Stroke Study) Magnetic Resonance Imaging Substudy.</article-title>             <source>Circulation</source>             <volume>112</volume>             <fpage>1644</fpage>             <lpage>1650</lpage>          </element-citation>
      </ref>
      <ref id="pone.0025930-Inzitari1">
        <label>20</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Inzitari</surname><given-names>D</given-names></name></person-group>             <year>2003</year>             <article-title>Leukoaraiosis: an independent risk factor for stroke?</article-title>             <source>Stroke</source>             <volume>34</volume>             <fpage>2067</fpage>             <lpage>2071</lpage>          </element-citation>
      </ref>
      <ref id="pone.0025930-Fazekas2">
        <label>21</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Fazekas</surname><given-names>F</given-names></name><name name-style="western"><surname>Kleinert</surname><given-names>R</given-names></name><name name-style="western"><surname>Roob</surname><given-names>G</given-names></name><name name-style="western"><surname>Kleinert</surname><given-names>G</given-names></name><name name-style="western"><surname>Kapeller</surname><given-names>P</given-names></name><etal/></person-group>             <year>1999</year>             <article-title>Histopathologic analysis of foci of signal loss on gradient-echo T2*-weighted MR images in patients with spontaneous intracerebral hemorrhage: evidence of microangiopathy-related microbleeds.</article-title>             <source>AJNR Am J Neuroradiol</source>             <volume>20</volume>             <fpage>637</fpage>             <lpage>642</lpage>          </element-citation>
      </ref>
      <ref id="pone.0025930-Vernooij1">
        <label>22</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Vernooij</surname><given-names>MW</given-names></name><name name-style="western"><surname>van der Lugt</surname><given-names>A</given-names></name><name name-style="western"><surname>Ikram</surname><given-names>MA</given-names></name><name name-style="western"><surname>Wielopolski</surname><given-names>PA</given-names></name><name name-style="western"><surname>Niessen</surname><given-names>WJ</given-names></name><etal/></person-group>             <year>2008</year>             <article-title>Prevalence and risk factors of cerebral microbleeds: the Rotterdam Scan Study.</article-title>             <source>Neurology</source>             <volume>70</volume>             <fpage>1208</fpage>             <lpage>1214</lpage>          </element-citation>
      </ref>
      <ref id="pone.0025930-Tanaka2">
        <label>23</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Tanaka</surname><given-names>H</given-names></name><name name-style="western"><surname>Ueda</surname><given-names>Y</given-names></name><name name-style="western"><surname>Hayashi</surname><given-names>M</given-names></name><name name-style="western"><surname>Date</surname><given-names>C</given-names></name><name name-style="western"><surname>Baba</surname><given-names>T</given-names></name><etal/></person-group>             <year>1982</year>             <article-title>Risk factors for cerebral hemorrhage and cerebral infarction in a Japanese rural community.</article-title>             <source>Stroke</source>             <volume>13</volume>             <fpage>62</fpage>             <lpage>73</lpage>          </element-citation>
      </ref>
      <ref id="pone.0025930-Yano1">
        <label>24</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Yano</surname><given-names>K</given-names></name><name name-style="western"><surname>Reed</surname><given-names>DM</given-names></name><name name-style="western"><surname>MacLean</surname><given-names>CJ</given-names></name></person-group>             <year>1989</year>             <article-title>Serum cholesterol and hemorrhagic stroke in the Honolulu Heart Program.</article-title>             <source>Stroke</source>             <volume>20</volume>             <fpage>1460</fpage>             <lpage>1465</lpage>          </element-citation>
      </ref>
      <ref id="pone.0025930-Konishi1">
        <label>25</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Konishi</surname><given-names>M</given-names></name><name name-style="western"><surname>Iso</surname><given-names>H</given-names></name><name name-style="western"><surname>Komachi</surname><given-names>Y</given-names></name><name name-style="western"><surname>Iida</surname><given-names>M</given-names></name><name name-style="western"><surname>Shimamoto</surname><given-names>T</given-names></name><etal/></person-group>             <year>1993</year>             <article-title>Associations of serum total cholesterol, different types of stroke, and stenosis distribution of cerebral arteries. The Akita Pathology Study.</article-title>             <source>Stroke</source>             <volume>24</volume>             <fpage>954</fpage>             <lpage>964</lpage>          </element-citation>
      </ref>
      <ref id="pone.0025930-Ueda1">
        <label>26</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Ueda</surname><given-names>K</given-names></name><name name-style="western"><surname>Hasuo</surname><given-names>Y</given-names></name><name name-style="western"><surname>Kiyohara</surname><given-names>Y</given-names></name><name name-style="western"><surname>Wada</surname><given-names>J</given-names></name><name name-style="western"><surname>Kawano</surname><given-names>H</given-names></name><etal/></person-group>             <year>1988</year>             <article-title>Intracerebral hemorrhage in a Japanese community, Hisayama: incidence, changing pattern during long-term follow-up, and related factors.</article-title>             <source>Stroke</source>             <volume>19</volume>             <fpage>48</fpage>             <lpage>52</lpage>          </element-citation>
      </ref>
      <ref id="pone.0025930-Iso1">
        <label>27</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Iso</surname><given-names>H</given-names></name><name name-style="western"><surname>Jacobs</surname><given-names>DR</given-names><suffix>Jr</suffix></name><name name-style="western"><surname>Wentworth</surname><given-names>D</given-names></name><name name-style="western"><surname>Neaton</surname><given-names>JD</given-names></name><name name-style="western"><surname>Cohen</surname><given-names>JD</given-names></name></person-group>             <year>1989</year>             <article-title>Serum cholesterol levels and six-year mortality from stroke in 350,977 men screened for the multiple risk factor intervention trial.</article-title>             <source>N Engl J Med</source>             <volume>320</volume>             <fpage>904</fpage>             <lpage>910</lpage>          </element-citation>
      </ref>
      <ref id="pone.0025930-Tatsumi1">
        <label>28</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Tatsumi</surname><given-names>S</given-names></name><name name-style="western"><surname>Shinohara</surname><given-names>M</given-names></name><name name-style="western"><surname>Yamamoto</surname><given-names>T</given-names></name></person-group>             <year>2008</year>             <article-title>Direct comparison of histology of microbleeds with postmortem MR images: a case report.</article-title>             <source>Cerebrovasc Dis</source>             <volume>26</volume>             <fpage>142</fpage>             <lpage>146</lpage>          </element-citation>
      </ref>
      <ref id="pone.0025930-Reed1">
        <label>29</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Reed</surname><given-names>DM</given-names></name></person-group>             <year>1990</year>             <article-title>The paradox of high risk of stroke in populations with low risk of coronary heart disease.</article-title>             <source>Am J Epidemiol</source>             <volume>131</volume>             <fpage>579</fpage>             <lpage>588</lpage>          </element-citation>
      </ref>
      <ref id="pone.0025930-Yamori1">
        <label>30</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Yamori</surname><given-names>Y</given-names></name><name name-style="western"><surname>Sato</surname><given-names>M</given-names></name><name name-style="western"><surname>Horie</surname><given-names>R</given-names></name></person-group>             <year>1976</year>             <article-title>Proceedings: Blood pressure and vascular lesions in SHR fed on a high-fat-cholesterol diet: a preliminary report.</article-title>             <source>Jpn Heart J</source>             <volume>17</volume>             <fpage>390</fpage>             <lpage>392</lpage>          </element-citation>
      </ref>
      <ref id="pone.0025930-Amarenco1">
        <label>31</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Amarenco</surname><given-names>P</given-names></name><name name-style="western"><surname>Bogousslavsky</surname><given-names>J</given-names></name><name name-style="western"><surname>Callahan</surname><given-names>A</given-names><suffix>3rd</suffix></name><name name-style="western"><surname>Goldstein</surname><given-names>LB</given-names></name><name name-style="western"><surname>Hennerici</surname><given-names>M</given-names></name><etal/></person-group>             <year>2006</year>             <article-title>High-dose atorvastatin after stroke or transient ischemic attack.</article-title>             <source>N Engl J Med</source>             <volume>355</volume>             <fpage>549</fpage>             <lpage>559</lpage>          </element-citation>
      </ref>
      <ref id="pone.0025930-Vergouwen1">
        <label>32</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Vergouwen</surname><given-names>MD</given-names></name><name name-style="western"><surname>de Haan</surname><given-names>RJ</given-names></name><name name-style="western"><surname>Vermeulen</surname><given-names>M</given-names></name><name name-style="western"><surname>Roos</surname><given-names>YB</given-names></name></person-group>             <year>2008</year>             <article-title>Statin treatment and the occurrence of hemorrhagic stroke in patients with a history of cerebrovascular disease.</article-title>             <source>Stroke</source>             <volume>39</volume>             <fpage>497</fpage>             <lpage>502</lpage>          </element-citation>
      </ref>
      <ref id="pone.0025930-Amarenco2">
        <label>33</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Amarenco</surname><given-names>P</given-names></name><name name-style="western"><surname>Labreuche</surname><given-names>J</given-names></name></person-group>             <year>2009</year>             <article-title>Lipid management in the prevention of stroke: review and updated meta-analysis of statins for stroke prevention.</article-title>             <source>Lancet Neurol</source>             <volume>8</volume>             <fpage>453</fpage>             <lpage>463</lpage>          </element-citation>
      </ref>
      <ref id="pone.0025930-Qureshi1">
        <label>34</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Qureshi</surname><given-names>AI</given-names></name><name name-style="western"><surname>Tuhrim</surname><given-names>S</given-names></name><name name-style="western"><surname>Broderick</surname><given-names>JP</given-names></name><name name-style="western"><surname>Batjer</surname><given-names>HH</given-names></name><name name-style="western"><surname>Hondo</surname><given-names>H</given-names></name><etal/></person-group>             <year>2001</year>             <article-title>Spontaneous intracerebral hemorrhage.</article-title>             <source>N Engl J Med</source>             <volume>344</volume>             <fpage>1450</fpage>             <lpage>1460</lpage>          </element-citation>
      </ref>
      <ref id="pone.0025930-Rothwell1">
        <label>35</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Rothwell</surname><given-names>PM</given-names></name></person-group>             <year>2005</year>             <article-title>Prevention of stroke in patients with diabetes mellitus and the metabolic syndrome.</article-title>             <source>Cerebrovasc Dis</source>             <volume>20</volume>             <supplement>Suppl 1</supplement>             <fpage>24</fpage>             <lpage>34</lpage>          </element-citation>
      </ref>
      <ref id="pone.0025930-Kim1">
        <label>36</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Kim</surname><given-names>BJ</given-names></name><name name-style="western"><surname>Lee</surname><given-names>SH</given-names></name><name name-style="western"><surname>Kang</surname><given-names>BS</given-names></name><name name-style="western"><surname>Yoon</surname><given-names>BW</given-names></name><name name-style="western"><surname>Roh</surname><given-names>JK</given-names></name></person-group>             <year>2008</year>             <article-title>Diabetes increases large artery diseases, but not small artery diseases in the brain.</article-title>             <source>J Neurol</source>             <volume>255</volume>             <fpage>1176</fpage>             <lpage>1181</lpage>          </element-citation>
      </ref>
    </ref-list>
    
  </back>
</article>